002294.SZ
Price:
$58.7
Market Cap:
$65.44B
Shenzhen Salubris Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of medicines for cardiovascular, anti-diabetic, antineoplastic, and orthopedic therapeutic in China. It offers cardiovascular and cerebrovascular products, such as allisartan isoproxil, benazepril hydrochloride, desloratadine, and clopidogrel bisulfate tablets, as well as bivalirudin and pamidronate disodium injections; recombinant SeV-hFGF2/dF Injection for the treatment of diabetic foot disease; and anti-tumor and orthopedics medicines. The company also provides anti-infection products comprising cefonicid sodium, ceftazidime, ceftriaxone sodium, cefonicid sodium, cefminox sodium, cefurox...[Read more]
Industry
Medical - Instruments & Supplies
IPO Date
2009-09-10
Stock Exchange
SHZ
Ticker
002294.SZ
According to Shenzhen Salubris Pharmaceuticals Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 64.69B. This represents a change of 38.13% compared to the average of 46.83B of the last 4 quarters.
The mean historical Enterprise Value of Shenzhen Salubris Pharmaceuticals Co., Ltd. over the last ten years is 29.85B. The current 64.69B Enterprise Value has changed 21.57% with respect to the historical average. Over the past ten years (40 quarters), 002294.SZ's Enterprise Value was at its highest in in the September 2025 quarter at 66.53B. The Enterprise Value was at its lowest in in the March 2020 quarter at 18.34B.
Average
29.85B
Median
29.75B
Minimum
19.90B
Maximum
42.19B
Discovering the peaks and valleys of Shenzhen Salubris Pharmaceuticals Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 45.83%
Maximum Annual Enterprise Value = 42.19B
Minimum Annual Increase = -52.84%
Minimum Annual Enterprise Value = 19.90B
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 33.46B | -4.74% |
| 2023 | 35.12B | 4.45% |
| 2022 | 33.62B | 29.28% |
| 2021 | 26.01B | -9.30% |
| 2020 | 28.67B | 43.22% |
| 2019 | 20.02B | 0.62% |
| 2018 | 19.90B | -52.84% |
| 2017 | 42.19B | 45.83% |
| 2016 | 28.93B | -5.33% |
| 2015 | 30.56B | 37.38% |
The current Enterprise Value of Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
34.07B
5-year avg
31.37B
10-year avg
29.85B
Shenzhen Salubris Pharmaceuticals Co., Ltd.’s Enterprise Value is less than Huadong Medicine Co., Ltd (74.23B), less than Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (65.12B), greater than Imeik Technology Development Co.,Ltd. (40.87B), less than Shanghai Pharmaceuticals Holding Co., Ltd (91.51B), greater than Haisco Pharmaceutical Group Co., Ltd. (62.98B), less than Zhejiang NHU Company Ltd. (74.74B), greater than Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (57.79B), less than Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (100.20B), greater than Gan & Lee Pharmaceuticals. (37.39B), greater than Hangzhou Tigermed Consulting Co., Ltd. (37.07B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 74.23B | $72.65B | |
| 65.12B | $62.70B | |
| 40.87B | $42.01B | |
| 91.51B | $66.64B | |
| 62.98B | $62.07B | |
| 74.74B | $74.14B | |
| 57.79B | $59.74B | |
| 100.20B | $74.70B | |
| 37.39B | $39.44B | |
| 37.07B | $36.96B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shenzhen Salubris Pharmaceuticals Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Shenzhen Salubris Pharmaceuticals Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Shenzhen Salubris Pharmaceuticals Co., Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ)?
What is the 3-year average Enterprise Value for Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ)?
What is the 5-year average Enterprise Value for Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ)?
How does the current Enterprise Value for Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) compare to its historical average?